Physician profile
Ricardo Castillo
NPI 1568471217
$9,231.83
in general payments reported to CMS, 2019-2025
41 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,951 · 2020: $1,077 · 2021: $1,246 · 2022: $1,549 · 2023: $1,173 · 2024: $828 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,346 · Honoraria: $63.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,345.57 |
| Honoraria | $63.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,114.72 | 2019-2025 | |
| Abbott Laboratories | $1,028.52 | 2019-2024 | Cardiomems |
| Boston Scientific Corporation | $760.42 | 2019-2025 | Synergy, Rotapro, General - Balloon Catheters |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $660.53 | 2019-2025 | Lifevest |
| Medtronic, INC. | $597.01 | 2021-2024 | Symplicity G3, Onyx Frontier |
| Inari Medical, INC. | $550.80 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $495.24 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $441.25 | 2021-2025 | Verquvo, Winrevair |
| Alnylam Pharmaceuticals INC. | $329.73 | 2020-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $274.64 | 2019-2025 | Camzyos |
| Abiomed | $262.00 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $256.07 | 2019-2024 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $249.45 | 2019-2024 | Opsumit, Uptravi |
| Pfizer INC. | $189.62 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $176.98 | 2024-2025 | Assure Wcd |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $172.31 | 2022-2025 | Injectafer |
| Edwards Lifesciences Corporation | $157.96 | 2019 | |
| Stryker Corporation | $152.31 | 2022-2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bardy Diagnostics, INC. | $147.79 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.96 | 2022-2025 | |
| Astellas Pharma US INC | $114.40 | 2020-2022 | |
| Penumbra, INC. | $113.82 | 2020 | |
| Chiesi USA, INC. | $102.53 | 2019-2025 | Kengreal |
| Angiodynamics, INC. | $85.63 | 2022-2025 | Alphavac |
| Medtronic Vascular, INC. | $78.77 | 2020 | |
| Bracco Diagnostics INC. | $70.91 | 2025 | |
| Janssen Scientific Affairs, LLC | $69.79 | 2019-2022 | |
| Becton, Dickinson and Company | $63.00 | 2025 | |
| Shockwave Medical, INC | $55.54 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.81 | 2023-2025 | Jardiance |
| Irhythm Technologies, INC. | $43.47 | 2024 | Zio Monitor, Zio Xt Patch |
| United Therapeutics Corporation | $38.09 | 2023-2024 | Orenitram, Tyvaso |
| Biotronik INC. | $37.73 | 2020-2021 | |
| Cardinal Health 200 LLC | $33.76 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $25.00 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $24.04 | 2021 | |
| Lantheus Medical Imaging, INC. | $23.52 | 2019 | |
| Amgen INC. | $20.88 | 2019 | |
| Asahi Intecc USA, INC. | $18.12 | 2021 | |
| Medtronic USA, INC. | $12.44 | 2020 | |
| Z-Medica, LLC | $10.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.